The Orchid and the Ashtray have become theatrical props in a process that should prize results over rhetoric. What began-presumably-as a civil-society effort to spotlight constructive engagement at WHO FCTC Conferences of the Parties has metastasized into a crude instrument of narrative control. When awards meant to encourage progress instead reward conformity to an orthodox line, they cease to be useful; they become propaganda.
Look at the record. Countries routinely lauded in advocacy circles are not always those producing the biggest declines in tobacco harm. According to WHO’s 2025 fact sheet, India’s adult tobacco prevalence fell from 33% in 2010 to an estimated 22% in 2025, and Thailand’s from 27% to roughly 20% over the same period-meaning both are unlikely to meet the WHO’s 30% reduction target by 2025. Meanwhile, Japan and Sweden, which have embraced pragmatic pathways for adult smokers-heating technologies in Japan, snus in Sweden-have achieved dramatic reductions in combustible cigarette use and some of the lowest smoking prevalences in their regions. Japan’s cigarette demand plunged by more than half between 2010 and 2022 as many smokers migrated to heated tobacco products; Sweden now records smoking prevalence near historic lows in Europe, with snus widely credited for much of that displacement.
Yet Japan and Sweden rarely figure as models in the awards-driven narrative. By contrast, countries that dutifully recite the same ideological script get celebrated, even when their outcomes lag. This is not benign favoritism-it is a perverse incentive structure. Awards that reward alignment with dogma rather than measurable public-health outcomes steer policy discussions away from what actually reduces death and disease and toward what looks good on a campaign placard.
The Philippines is a cautionary example of how this dynamic can malign earnest, context-sensitive policymaking. With roughly 16 million adult smokers, policymaking must balance public health goals with adult autonomy, farmer livelihoods and enforceable regulation.
Proposals to create a working group of state parties and an expert advisory arm-ideas meant to resolve complexity, not to obstruct progress-were nonetheless caricatured by outside observers. That matters, because it signals to national delegations that independence and nuance will be punished with ridicule rather than assessed on their merits. It is encouraging, however, that at COP10 the Philippines received formal recognition from Committee A for a whole-of-government approach that acknowledged national realities while cooperating internationally-proof that the treaty process itself can reward prudent, pragmatic engagement.
The deeper problem is institutional: observers observe; Parties negotiate. The Global Alliance for Tobacco Control (GATC), which hands out these ‘awards’, is merely an observer. When outside actors such as the GATC begin to masquerade as scorekeepers and moral arbiters-handing out Orchids and Ashtrays according to a narrow ideological script-the clarity of that architecture erodes. Negotiation requires trade-offs: taxation and enforcement, swapping illicit-trade control for customs capacity, supporting farmers through transition, and now the thorny regulation of alternative nicotine products that may be less harmful than combustible cigarettes. These are not trivial choices; they deserve rigorous evidence, transparent metrics and a respect for national sovereignty-not performative shaming.
If advocacy awards are to retain any credibility, they must change their rubric. Celebrate outcomes, not orthodoxy. Reward meaningful declines in combustible tobacco use, demonstrable reductions in disease burden, and policies that responsibly expand safer alternatives for adult smokers. Publish transparent, data-driven criteria. Include independent scientific review. And stop using public humiliation as a substitute for debate.
Public-health advocacy should be about saving lives, not scoring political points. Treat adult smokers as citizens with rights, recognize that harm reduction can be part of a realistic public-health toolkit, and give nations credit for measurable progress-however uncomfortable it may be for an ideological posture. The moment observers put virtue-signaling ahead of verifiable outcomes, they compromise the very cause they claim to advance. It is time to retire the spectacle and restore evidence to the center of global tobacco-control recognition.